These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30880441)

  • 1. Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.
    Azizi M; Schmieder RE; Mahfoud F; Weber MA; Daemen J; Lobo MD; Sharp ASP; Bloch MJ; Basile J; Wang Y; Saxena M; Lurz P; Rader F; Sayer J; Fisher NDL; Fouassier D; Barman NC; Reeve-Stoffer H; McClure C; Kirtane AJ;
    Circulation; 2019 May; 139(22):2542-2553. PubMed ID: 30880441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial.
    Azizi M; Mahfoud F; Weber MA; Sharp ASP; Schmieder RE; Lurz P; Lobo MD; Fisher NDL; Daemen J; Bloch MJ; Basile J; Sanghvi K; Saxena M; Gosse P; Jenkins JS; Levy T; Persu A; Kably B; Claude L; Reeve-Stoffer H; McClure C; Kirtane AJ;
    JAMA Cardiol; 2022 Dec; 7(12):1244-1252. PubMed ID: 36350593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program.
    Azizi M; Sharp ASP; Fisher NDL; Weber MA; Lobo MD; Daemen J; Lurz P; Mahfoud F; Schmieder RE; Basile J; Bloch MJ; Saxena M; Wang Y; Sanghvi K; Jenkins JS; Devireddy C; Rader F; Gosse P; Claude L; Augustin DA; McClure CK; Kirtane AJ;
    Circulation; 2024 Mar; 149(10):747-759. PubMed ID: 37883784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation.
    Azizi M; Daemen J; Lobo MD; Mahfoud F; Sharp ASP; Schmieder RE; Wang Y; Saxena M; Lurz P; Sayer J; Bloch MJ; Basile J; Weber MA; Rump LC; Levy T; Sapoval M; Sanghvi K; Rader F; Fisher NDL; Gosse P; Abraham J; Claude L; Barman NC; McClure CK; Liu Y; Kirtane AJ;
    JACC Cardiovasc Interv; 2020 Dec; 13(24):2922-2933. PubMed ID: 33357531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.
    Azizi M; Schmieder RE; Mahfoud F; Weber MA; Daemen J; Davies J; Basile J; Kirtane AJ; Wang Y; Lobo MD; Saxena M; Feyz L; Rader F; Lurz P; Sayer J; Sapoval M; Levy T; Sanghvi K; Abraham J; Sharp ASP; Fisher NDL; Bloch MJ; Reeve-Stoffer H; Coleman L; Mullin C; Mauri L;
    Lancet; 2018 Jun; 391(10137):2335-2345. PubMed ID: 29803590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.
    Azizi M; Saxena M; Wang Y; Jenkins JS; Devireddy C; Rader F; Fisher NDL; Schmieder RE; Mahfoud F; Lindsey J; Sanghvi K; Todoran TM; Pacella J; Flack J; Daemen J; Sharp ASP; Lurz P; Bloch MJ; Weber MA; Lobo MD; Basile J; Claude L; Reeve-Stoffer H; McClure CK; Kirtane AJ;
    JAMA; 2023 Feb; 329(8):651-661. PubMed ID: 36853250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials.
    Kirtane AJ; Sharp ASP; Mahfoud F; Fisher NDL; Schmieder RE; Daemen J; Lobo MD; Lurz P; Basile J; Bloch MJ; Weber MA; Saxena M; Wang Y; Sanghvi K; Jenkins JS; Devireddy C; Rader F; Gosse P; Sapoval M; Barman NC; Claude L; Augustin D; Thackeray L; Mullin CM; Azizi M;
    JAMA Cardiol; 2023 May; 8(5):464-473. PubMed ID: 36853627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
    Azizi M; Sanghvi K; Saxena M; Gosse P; Reilly JP; Levy T; Rump LC; Persu A; Basile J; Bloch MJ; Daemen J; Lobo MD; Mahfoud F; Schmieder RE; Sharp ASP; Weber MA; Sapoval M; Fong P; Pathak A; Lantelme P; Hsi D; Bangalore S; Witkowski A; Weil J; Kably B; Barman NC; Reeve-Stoffer H; Coleman L; McClure CK; Kirtane AJ;
    Lancet; 2021 Jun; 397(10293):2476-2486. PubMed ID: 34010611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.
    Kandzari DE; Weber MA; Pathak A; Zidar JP; Saxena M; David SW; Schmieder RE; Janas AJ; Langer C; Persu A; Mendelsohn FO; Ameloot K; Foster M; Fischell TA; Parise H; Mahfoud F
    Circulation; 2024 Jun; 149(24):1875-1884. PubMed ID: 38587557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO Study.
    Gosse P; Cremer A; Kirtane AJ; Lobo MD; Saxena M; Daemen J; Wang Y; Stegbauer J; Weber MA; Abraham J; Kario K; Bangalore S; Claude L; Liu Y; Azizi M
    Hypertension; 2021 Feb; 77(2):529-536. PubMed ID: 33356403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial.
    Mahfoud F; Bloch MJ; Azizi M; Wang Y; Schmieder RE; Lobo MD; Sharp ASP; Daemen J; Basile J; Weber MA; Scicli AP; McClure CK; Kirtane AJ
    EuroIntervention; 2021 Dec; 17(12):e1024-e1032. PubMed ID: 34236037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial.
    Wang J; Yin Y; Lu C; Lu Z; Hu J; Wang Y; Ge J; Jiang H; Yao C; Yan X; Ma W; Qi X; Dang Y; Chen S; Zhu J; Wang D; Ding C; Wang W; Liu J; Wang Y; Li H; Pan Z; Cui K; Li C; Liang X; Chen W; Sobotka PA; Zhang J; Esler M; Sun N; Chen M; Huo Y
    EClinicalMedicine; 2024 Jun; 72():102626. PubMed ID: 38756107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.
    Kandzari DE; Townsend RR; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; Konstantinidis D; Choi J; East C; Lauder L; Cohen DL; Kobayashi T; Schmid A; Lee DP; Ma A; Weil J; Agdirlioglu T; Schlaich MP; Shetty S; Devireddy CM; Lea J; Aoki J; Sharp ASP; Anderson R; Fahy M; DeBruin V; Brar S; Böhm M;
    J Am Coll Cardiol; 2023 Nov; 82(19):1809-1823. PubMed ID: 37914510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED.
    Townsend RR; Ferdinand KC; Kandzari DE; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; David S; Steigerwalt S; Walton A; Hopper I; Bertolet B; Sharif F; Fengler K; Fahy M; Hettrick DA; Brar S; Böhm M
    Hypertension; 2024 May; 81(5):1095-1105. PubMed ID: 38314554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
    Mahfoud F; Kandzari DE; Kario K; Townsend RR; Weber MA; Schmieder RE; Tsioufis K; Pocock S; Dimitriadis K; Choi JW; East C; D'Souza R; Sharp ASP; Ewen S; Walton A; Hopper I; Brar S; McKenna P; Fahy M; Böhm M
    Lancet; 2022 Apr; 399(10333):1401-1410. PubMed ID: 35390320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence.
    Weber MA; Mahfoud F; Schmieder RE; Kandzari DE; Tsioufis KP; Townsend RR; Kario K; Böhm M; Sharp ASP; Davies JE; Osborn JW; Fink GD; Euler DE; Cohen DL; Schlaich MP; Esler MD
    JACC Cardiovasc Interv; 2019 Jun; 12(12):1095-1105. PubMed ID: 31221299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
    Bhatt DL; Vaduganathan M; Kandzari DE; Leon MB; Rocha-Singh K; Townsend RR; Katzen BT; Oparil S; Brar S; DeBruin V; Fahy M; Bakris GL;
    Lancet; 2022 Oct; 400(10361):1405-1416. PubMed ID: 36130612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
    Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K; Rommel KP; Lapusca R; Blazek S; Besler C; Hartung P; von Roeder M; Kresoja KP; Desch S; Thiele H; Lurz P
    Hypertension; 2019 Aug; 74(2):341-348. PubMed ID: 31203726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications.
    Pathak A; Rudolph UM; Saxena M; Zeller T; Müller-Ehmsen J; Lipsic E; Schmieder RE; Sievert H; Halbach M; Sharif F; Parise H; Fischell TA; Weber MA; Kandzari DE; Mahfoud F
    EuroIntervention; 2023 Sep; 19(7):602-611. PubMed ID: 37427416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.